Global Hepatitis B Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 111 pages | ID: G353F1D46278EN
LP Information

Abstracts

According to this study, the global Hepatitis B Treatment market size will reach US$ million by 2031.

It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Hepatitis B Treatment Industry Forecast” looks at past sales and reviews total world Hepatitis B Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis B Treatment sales for 2025 through 2031. With Hepatitis B Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis B Treatment industry.

This Insight Report provides a comprehensive analysis of the global Hepatitis B Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hepatitis B Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hepatitis B Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis B Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis B Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Acute
• Chronic

Segmentation by Application:

• Immune Modulator Drugs
• Antiviral Drugs

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Accord Healthcare Inc.
• Apotex Corp.
• Arbutus Biopharma
• Bristol-Myers Squibb Company
• Gilead Sciences
• GlaxoSmithKline
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Par Pharmaceutical
• Teva Pharmaceuticals
• Zydus Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hepatitis B Treatment Market Size (2020-2031)
  2.1.2 Hepatitis B Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Hepatitis B Treatment by Country/Region (2020, 2024 & 2031)
2.2 Hepatitis B Treatment Segment by Type
  2.2.1 Acute
  2.2.2 Chronic
2.3 Hepatitis B Treatment Market Size by Type
  2.3.1 Hepatitis B Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Hepatitis B Treatment Market Size Market Share by Type (2020-2025)
2.4 Hepatitis B Treatment Segment by Application
  2.4.1 Immune Modulator Drugs
  2.4.2 Antiviral Drugs
2.5 Hepatitis B Treatment Market Size by Application
  2.5.1 Hepatitis B Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Hepatitis B Treatment Market Size Market Share by Application (2020-2025)

3 HEPATITIS B TREATMENT MARKET SIZE BY PLAYER

3.1 Hepatitis B Treatment Market Size Market Share by Player
  3.1.1 Global Hepatitis B Treatment Revenue by Player (2020-2025)
  3.1.2 Global Hepatitis B Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Hepatitis B Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HEPATITIS B TREATMENT BY REGION

4.1 Hepatitis B Treatment Market Size by Region (2020-2025)
4.2 Global Hepatitis B Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hepatitis B Treatment Market Size Growth (2020-2025)
4.4 APAC Hepatitis B Treatment Market Size Growth (2020-2025)
4.5 Europe Hepatitis B Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Hepatitis B Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Hepatitis B Treatment Market Size by Country (2020-2025)
5.2 Americas Hepatitis B Treatment Market Size by Type (2020-2025)
5.3 Americas Hepatitis B Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hepatitis B Treatment Market Size by Region (2020-2025)
6.2 APAC Hepatitis B Treatment Market Size by Type (2020-2025)
6.3 APAC Hepatitis B Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hepatitis B Treatment Market Size by Country (2020-2025)
7.2 Europe Hepatitis B Treatment Market Size by Type (2020-2025)
7.3 Europe Hepatitis B Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hepatitis B Treatment by Region (2020-2025)
8.2 Middle East & Africa Hepatitis B Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Hepatitis B Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HEPATITIS B TREATMENT MARKET FORECAST

10.1 Global Hepatitis B Treatment Forecast by Region (2026-2031)
  10.1.1 Global Hepatitis B Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Hepatitis B Treatment Forecast
  10.1.3 APAC Hepatitis B Treatment Forecast
  10.1.4 Europe Hepatitis B Treatment Forecast
  10.1.5 Middle East & Africa Hepatitis B Treatment Forecast
10.2 Americas Hepatitis B Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Hepatitis B Treatment Forecast
  10.2.2 Canada Market Hepatitis B Treatment Forecast
  10.2.3 Mexico Market Hepatitis B Treatment Forecast
  10.2.4 Brazil Market Hepatitis B Treatment Forecast
10.3 APAC Hepatitis B Treatment Forecast by Region (2026-2031)
  10.3.1 China Hepatitis B Treatment Market Forecast
  10.3.2 Japan Market Hepatitis B Treatment Forecast
  10.3.3 Korea Market Hepatitis B Treatment Forecast
  10.3.4 Southeast Asia Market Hepatitis B Treatment Forecast
  10.3.5 India Market Hepatitis B Treatment Forecast
  10.3.6 Australia Market Hepatitis B Treatment Forecast
10.4 Europe Hepatitis B Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Hepatitis B Treatment Forecast
  10.4.2 France Market Hepatitis B Treatment Forecast
  10.4.3 UK Market Hepatitis B Treatment Forecast
  10.4.4 Italy Market Hepatitis B Treatment Forecast
  10.4.5 Russia Market Hepatitis B Treatment Forecast
10.5 Middle East & Africa Hepatitis B Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Hepatitis B Treatment Forecast
  10.5.2 South Africa Market Hepatitis B Treatment Forecast
  10.5.3 Israel Market Hepatitis B Treatment Forecast
  10.5.4 Turkey Market Hepatitis B Treatment Forecast
10.6 Global Hepatitis B Treatment Forecast by Type (2026-2031)
10.7 Global Hepatitis B Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Hepatitis B Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Accord Healthcare Inc.
  11.1.1 Accord Healthcare Inc. Company Information
  11.1.2 Accord Healthcare Inc. Hepatitis B Treatment Product Offered
  11.1.3 Accord Healthcare Inc. Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Accord Healthcare Inc. Main Business Overview
  11.1.5 Accord Healthcare Inc. Latest Developments
11.2 Apotex Corp.
  11.2.1 Apotex Corp. Company Information
  11.2.2 Apotex Corp. Hepatitis B Treatment Product Offered
  11.2.3 Apotex Corp. Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Apotex Corp. Main Business Overview
  11.2.5 Apotex Corp. Latest Developments
11.3 Arbutus Biopharma
  11.3.1 Arbutus Biopharma Company Information
  11.3.2 Arbutus Biopharma Hepatitis B Treatment Product Offered
  11.3.3 Arbutus Biopharma Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Arbutus Biopharma Main Business Overview
  11.3.5 Arbutus Biopharma Latest Developments
11.4 Bristol-Myers Squibb Company
  11.4.1 Bristol-Myers Squibb Company Company Information
  11.4.2 Bristol-Myers Squibb Company Hepatitis B Treatment Product Offered
  11.4.3 Bristol-Myers Squibb Company Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bristol-Myers Squibb Company Main Business Overview
  11.4.5 Bristol-Myers Squibb Company Latest Developments
11.5 Gilead Sciences
  11.5.1 Gilead Sciences Company Information
  11.5.2 Gilead Sciences Hepatitis B Treatment Product Offered
  11.5.3 Gilead Sciences Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Gilead Sciences Main Business Overview
  11.5.5 Gilead Sciences Latest Developments
11.6 GlaxoSmithKline
  11.6.1 GlaxoSmithKline Company Information
  11.6.2 GlaxoSmithKline Hepatitis B Treatment Product Offered
  11.6.3 GlaxoSmithKline Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 GlaxoSmithKline Main Business Overview
  11.6.5 GlaxoSmithKline Latest Developments
11.7 Lupin Pharmaceuticals
  11.7.1 Lupin Pharmaceuticals Company Information
  11.7.2 Lupin Pharmaceuticals Hepatitis B Treatment Product Offered
  11.7.3 Lupin Pharmaceuticals Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Lupin Pharmaceuticals Main Business Overview
  11.7.5 Lupin Pharmaceuticals Latest Developments
11.8 Merck & Co., Inc.
  11.8.1 Merck & Co., Inc. Company Information
  11.8.2 Merck & Co., Inc. Hepatitis B Treatment Product Offered
  11.8.3 Merck & Co., Inc. Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Merck & Co., Inc. Main Business Overview
  11.8.5 Merck & Co., Inc. Latest Developments
11.9 Par Pharmaceutical
  11.9.1 Par Pharmaceutical Company Information
  11.9.2 Par Pharmaceutical Hepatitis B Treatment Product Offered
  11.9.3 Par Pharmaceutical Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Par Pharmaceutical Main Business Overview
  11.9.5 Par Pharmaceutical Latest Developments
11.10 Teva Pharmaceuticals
  11.10.1 Teva Pharmaceuticals Company Information
  11.10.2 Teva Pharmaceuticals Hepatitis B Treatment Product Offered
  11.10.3 Teva Pharmaceuticals Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Teva Pharmaceuticals Main Business Overview
  11.10.5 Teva Pharmaceuticals Latest Developments
11.11 Zydus Pharmaceuticals
  11.11.1 Zydus Pharmaceuticals Company Information
  11.11.2 Zydus Pharmaceuticals Hepatitis B Treatment Product Offered
  11.11.3 Zydus Pharmaceuticals Hepatitis B Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Zydus Pharmaceuticals Main Business Overview
  11.11.5 Zydus Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hepatitis B Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Hepatitis B Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Acute
Table 4. Major Players of Chronic
Table 5. Hepatitis B Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Hepatitis B Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Hepatitis B Treatment Market Size Market Share by Type (2020-2025)
Table 8. Hepatitis B Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Hepatitis B Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Hepatitis B Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Hepatitis B Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Hepatitis B Treatment Revenue Market Share by Player (2020-2025)
Table 13. Hepatitis B Treatment Key Players Head office and Products Offered
Table 14. Hepatitis B Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hepatitis B Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Hepatitis B Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Hepatitis B Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Hepatitis B Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Hepatitis B Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Hepatitis B Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Hepatitis B Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Hepatitis B Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Hepatitis B Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Hepatitis B Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Hepatitis B Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Hepatitis B Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Hepatitis B Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Hepatitis B Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Hepatitis B Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Hepatitis B Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Hepatitis B Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Hepatitis B Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Hepatitis B Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Hepatitis B Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Hepatitis B Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hepatitis B Treatment
Table 39. Key Market Challenges & Risks of Hepatitis B Treatment
Table 40. Key Industry Trends of Hepatitis B Treatment
Table 41. Global Hepatitis B Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Hepatitis B Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Hepatitis B Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Hepatitis B Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Accord Healthcare Inc. Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 46. Accord Healthcare Inc. Hepatitis B Treatment Product Offered
Table 47. Accord Healthcare Inc. Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Accord Healthcare Inc. Main Business
Table 49. Accord Healthcare Inc. Latest Developments
Table 50. Apotex Corp. Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 51. Apotex Corp. Hepatitis B Treatment Product Offered
Table 52. Apotex Corp. Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Apotex Corp. Main Business
Table 54. Apotex Corp. Latest Developments
Table 55. Arbutus Biopharma Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 56. Arbutus Biopharma Hepatitis B Treatment Product Offered
Table 57. Arbutus Biopharma Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Arbutus Biopharma Main Business
Table 59. Arbutus Biopharma Latest Developments
Table 60. Bristol-Myers Squibb Company Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Company Hepatitis B Treatment Product Offered
Table 62. Bristol-Myers Squibb Company Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bristol-Myers Squibb Company Main Business
Table 64. Bristol-Myers Squibb Company Latest Developments
Table 65. Gilead Sciences Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 66. Gilead Sciences Hepatitis B Treatment Product Offered
Table 67. Gilead Sciences Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Gilead Sciences Main Business
Table 69. Gilead Sciences Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 71. GlaxoSmithKline Hepatitis B Treatment Product Offered
Table 72. GlaxoSmithKline Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. GlaxoSmithKline Main Business
Table 74. GlaxoSmithKline Latest Developments
Table 75. Lupin Pharmaceuticals Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 76. Lupin Pharmaceuticals Hepatitis B Treatment Product Offered
Table 77. Lupin Pharmaceuticals Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Lupin Pharmaceuticals Main Business
Table 79. Lupin Pharmaceuticals Latest Developments
Table 80. Merck & Co., Inc. Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 81. Merck & Co., Inc. Hepatitis B Treatment Product Offered
Table 82. Merck & Co., Inc. Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Merck & Co., Inc. Main Business
Table 84. Merck & Co., Inc. Latest Developments
Table 85. Par Pharmaceutical Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 86. Par Pharmaceutical Hepatitis B Treatment Product Offered
Table 87. Par Pharmaceutical Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Par Pharmaceutical Main Business
Table 89. Par Pharmaceutical Latest Developments
Table 90. Teva Pharmaceuticals Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 91. Teva Pharmaceuticals Hepatitis B Treatment Product Offered
Table 92. Teva Pharmaceuticals Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Teva Pharmaceuticals Main Business
Table 94. Teva Pharmaceuticals Latest Developments
Table 95. Zydus Pharmaceuticals Details, Company Type, Hepatitis B Treatment Area Served and Its Competitors
Table 96. Zydus Pharmaceuticals Hepatitis B Treatment Product Offered
Table 97. Zydus Pharmaceuticals Hepatitis B Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Zydus Pharmaceuticals Main Business
Table 99. Zydus Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Hepatitis B Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hepatitis B Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Hepatitis B Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Hepatitis B Treatment Sales Market Share by Country/Region (2024)
Figure 8. Hepatitis B Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Hepatitis B Treatment Market Size Market Share by Type in 2024
Figure 10. Hepatitis B Treatment in Immune Modulator Drugs
Figure 11. Global Hepatitis B Treatment Market: Immune Modulator Drugs (2020-2025) & ($ millions)
Figure 12. Hepatitis B Treatment in Antiviral Drugs
Figure 13. Global Hepatitis B Treatment Market: Antiviral Drugs (2020-2025) & ($ millions)
Figure 14. Global Hepatitis B Treatment Market Size Market Share by Application in 2024
Figure 15. Global Hepatitis B Treatment Revenue Market Share by Player in 2024
Figure 16. Global Hepatitis B Treatment Market Size Market Share by Region (2020-2025)
Figure 17. Americas Hepatitis B Treatment Market Size 2020-2025 ($ millions)
Figure 18. APAC Hepatitis B Treatment Market Size 2020-2025 ($ millions)
Figure 19. Europe Hepatitis B Treatment Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Hepatitis B Treatment Market Size 2020-2025 ($ millions)
Figure 21. Americas Hepatitis B Treatment Value Market Share by Country in 2024
Figure 22. United States Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Hepatitis B Treatment Market Size Market Share by Region in 2024
Figure 27. APAC Hepatitis B Treatment Market Size Market Share by Type (2020-2025)
Figure 28. APAC Hepatitis B Treatment Market Size Market Share by Application (2020-2025)
Figure 29. China Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. India Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Hepatitis B Treatment Market Size Market Share by Country in 2024
Figure 36. Europe Hepatitis B Treatment Market Size Market Share by Type (2020-2025)
Figure 37. Europe Hepatitis B Treatment Market Size Market Share by Application (2020-2025)
Figure 38. Germany Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. France Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Hepatitis B Treatment Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Hepatitis B Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Hepatitis B Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Hepatitis B Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 52. APAC Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 53. Europe Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 55. United States Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 56. Canada Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 57. Mexico Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 58. Brazil Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 59. China Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 60. Japan Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 61. Korea Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 63. India Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 64. Australia Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 65. Germany Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 66. France Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 67. UK Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 68. Italy Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 69. Russia Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 70. Egypt Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 71. South Africa Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 72. Israel Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 73. Turkey Hepatitis B Treatment Market Size 2026-2031 ($ millions)
Figure 74. Global Hepatitis B Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Hepatitis B Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Hepatitis B Treatment Market Size 2026-2031 ($ millions)